Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Simon Fifer, Thames Kularatne, Marcus Tan, Fraser Drummond & John Rule. (2023) Understanding Treatment Preferences Among People Living with HIV in Australia: A Discrete Choice Experiment. Patient Preference and Adherence 17, pages 1825-1843.
Read now
Read now
Articles from other publishers (8)
Ivana Homerova, Avani Patel & Derek C. Macallan. (2022)
‘We want it all’:
ART
preferences assessed by
D
esirability of
O
utcome
R
anking
. HIV Medicine 24:5, pages 588-595.
Crossref
Crossref
Vasiliki Chounta, Sonya J. Snedecor, Sterling Wu & Nicolas Van de Velde. (2022) Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection. BMC Infectious Diseases 22:1.
Crossref
Crossref
Heather Gelhorn, Cindy Garris, Erin Arthurs, Frank Spinelli, Katelyn Cutts, Gin Nie Chua, Hannah Collacott, Bertrand Lebouché, Erik Lowman, Howard Rice & Sebastian Heidenreich. (2022) Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada. Journal of Personalized Medicine 12:3, pages 334.
Crossref
Crossref
Antonio Antela, Antonio Rivero, Josep M Llibre, Santiago Moreno, Antonio Antela, Josep M Llibre, Santiago Moreno, Antonio Rivero, Marta Alonso Montero, Enrique Bernal, José Ramón Blanco Ramos, Manuel Castaño, David Dalmau Juanola, Belén de la Fuente García, Carlos Dueñas, Nuria Espinosa, Vicente Estrada, María José Galindo Puerto, Miguel García del Toro, Juan González, Miguel Górgolas, Carmen Hidalgo-Tenorio, Hernando Knobel Freu, Juan Carlos López Bernaldo de Quirós, Juan Macías Sánchez, Carlos Martín Ruíz, Esteban Martínez Chamorro, Mar Masía, Máximo Miguelez, Celia Miralles, Julián Olalla, Esteban Ribera Pascuet, Francisco Rodríguez-Vidigal, Rafael Rubio & Santos Jesús. (2021) Redefining therapeutic success in HIV patients: an expert view. Journal of Antimicrobial Chemotherapy 76:10, pages 2501-2518.
Crossref
Crossref
Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu & Fitalew Agimass Taye. (2021) Patients’ preferences for antiretroviral therapy service provision: a systematic review. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Angelica Geter FugersonMadeline Y. SuttonDonna Hubbard McCree. (2019) Social and Structural Determinants of HIV Treatment and Care Among Hispanic Women and Latinas Living with HIV Infection in the United States: A Qualitative Review: 2008–2018. Health Equity 3:1, pages 581-587.
Crossref
Crossref
Ellen F. Eaton, Ashutosh Tamhane, Thibaut Davy-Mendez, Richard D. Moore, W. Christopher Mathews, Michael S. Saag, Michael J. Mugavero, Christina M. Wyatt & Orlando M. Gutierrez. (2019) Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART. JAIDS Journal of Acquired Immune Deficiency Syndromes 81:1, pages e6-e9.
Crossref
Crossref
Vandra C. Harris, Anne R. Links, Jonathan Walsh, Desi P. Schoo, Andrew H. Lee, David E. Tunkel & Emily F. Boss. (2018) A Systematic Review of Race/Ethnicity and Parental Treatment Decision-Making. Clinical Pediatrics 57:12, pages 1453-1464.
Crossref
Crossref